BDBM85517 CAS_171436-38-7::SL-NH2::SLIGRL-NH2

SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-[#8])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](-[#7])=O

InChI Key InChIKey=SGPMJRPYYIJZPC-JYAZKYGWSA-N

Data  1 KI  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 85517   

TargetProteinase-activated receptor 2(RAT)
The University Of Calgary

Curated by PDSP Ki Database
LigandPNGBDBM85517(CAS_171436-38-7 | SL-NH2 | SLIGRL-NH2)
Affinity DataKi:  260nMMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetProteinase-activated receptor 2(Homo sapiens (Human))
The University Of Queensland

Curated by ChEMBL
LigandPNGBDBM85517(CAS_171436-38-7 | SL-NH2 | SLIGRL-NH2)
Affinity DataEC50:  5.00E+3nMAssay Description:Agonist activity at PAR2 (unknown origin) by cell-based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 2(Homo sapiens (Human))
The University Of Queensland

Curated by ChEMBL
LigandPNGBDBM85517(CAS_171436-38-7 | SL-NH2 | SLIGRL-NH2)
Affinity DataEC50:  1.00E+4nMAssay Description:Agonist activity at human PAR2 expressed in HEK293T cells assessed as effect on intracellular calcium mobilization by R-SAT assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 2(Homo sapiens (Human))
The University Of Queensland

Curated by ChEMBL
LigandPNGBDBM85517(CAS_171436-38-7 | SL-NH2 | SLIGRL-NH2)
Affinity DataEC50:  4.20E+3nMAssay Description:Agonist activity at PAR2 in human HT-29 cells assessed as increase in intracellular calcium releaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed